Aurinia Pharmaceuticals (AUPH) Operating Income (QoQ) (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) Operating Income (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.62% |
| Dec 31, 2025 | 11.75% |
| Sep 30, 2025 | 48.11% |
| Jun 30, 2025 | -8.07% |
| Mar 31, 2025 | 1,408.99% |
| Dec 31, 2024 | -114.21% |
| Sep 30, 2024 | 876.47% |
| Jun 30, 2024 | 88.58% |
| Mar 31, 2024 | 55.34% |
| Dec 31, 2023 | -82.46% |
| Sep 30, 2023 | -0.58% |
| Jun 30, 2023 | 45.34% |
| Mar 31, 2023 | -5.28% |
| Dec 31, 2022 | -195.82% |
| Sep 30, 2022 | 73.61% |
| Jun 30, 2022 | 5.00% |
| Mar 31, 2022 | -15.83% |
| Dec 31, 2021 | 35.05% |
| Sep 30, 2021 | -6.83% |
| Jun 30, 2021 | 6.74% |